Science / Study

A randomized, double-blind, placebo-controlled study of 244 post-menopausal women found that supplementing with low-dose menatto® vitamin K2 (MK-7) for 3 years helped bind calcium to bones, supporting healthy bone mineral density.

A randomized, double-blind study of 94 participants found 1 year of supplementation with menatto® vitamin K2 (MK-7) helped support healthy bone mineral density in middle-aged men and women.

A randomized, double-blind study found that menatto® vitamin K2 (MK-7) helped with the carboxylation of osteocalcin.* (Carboxylated osteocalcin aids in binding calcium to bone, which supports bone strength and health.*)

In a randomized, double-blind, placebo-controlled study, menatto® vitamin K2 (MK-7) effectively raised blood levels of vitamin K2 in children and helped ensure the proper level of carboxylated osteocalcin, a protein that regulates healthy bone formation.

A randomized, double-blind, placebo-controlled study of healthy post-menopausal women found that 3 years of supplementation with menatto® vitamin K2 (MK-7) supported healthy blood vessel elasticity, benefiting cardiovascular health.

Taking menatto® vitamin K2 (MK7) resulted in more stable and higher blood levels of vitamin K (7-8 fold higher) than vitamin K1. In addition, menatto® supported the carboxylation of osteocalcin, a protein that helps calcium bind to bone and thus keeps bones strong.*